查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726309

全球肠道疾病检测市场：市场规模、份额、趋势分析（按疾病和地区）、细分市场预测（2025-2030 年）

Enteric Disease Testing Market Size, Share, & Trends Analysis Report By Disease (Bacterial, Viral, Parasitic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

肠病检测市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球肠道疾病检测市场规模预计到2030年将达到47.4亿美元，2025年至2030年期间的复合年增长率为3.1%。

肠道疾病盛行率的不断上升和先进诊断技术的不断普及是推动市场成长的主要因素。根据美国疾病管制与预防中心的数据，全球每年记录的伤寒病例接近1,100万例，副伤寒病例约500万例。

生活方式和消费者偏好的改变导致多个地区胃肠道感染疾病发病率的增加，从而推动了对肠道疾病检测解决方案的需求。人们越来越意识到，如果不及时干预，肠道疾病可能会造成严重后果，因此检测数量正在增加。多个政府机构对保护公众健康和预防疫情的重视也有望在未来几年推动该产业的发展。

政府改善医疗保健的措施（如筛检计划、宣传宣传活动和特定福利计划）预计将推动市场成长。例如，在美国，疾病管制与预防中心（CDC）使用肠道疾病反应、调查和协调系统（SEDRIC）有效监测和应对与食品和动物接触有关的疾病爆发。他们还帮助管理 BEAM（细菌、肠道细菌、变形虫、真菌）仪表板，向大众提供肠道疾病爆发数据。预计此类努力将导致预测期内进行的测试数量增加。

肠病检测市场：概述

  • 2024 年，细菌类药物占据肠道疾病检测市场的 60% 左右，这是因为大肠桿菌、大肠桿菌性结肠炎、志贺氏菌和沙门氏菌等大量细菌会导致常见的肠道疾病。
  • 由于受污染的水和食物、各地区卫生系统差以及缺乏适当的卫生条件而导致的肠道疾病病例不断增加，寄生虫学领域预计将会成长。
  • 各国政府越来越重视提供采用先进诊断技术的优质医疗服务，以防止疫情大规模爆发，预计将创造成长机会。
  • 由于强大的医疗保健基础设施、主要诊断技术开发商和生物技术公司的存在等因素，北美在 2024 年占据了全球产业的主导地位。
  • 预计区域机构和政府资助的研究计画的预防工作将刺激成长。
  • 2025年2月，生物梅里埃宣布其新的检测解决方案BIOFIRE FILMARRAY胃肠道（GI）面板Mid.已获得美国FDA批准。

目录

第一章 分析方法与范围

第二章执行摘要

3. 肠道疾病检测市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 肠道疾病检测市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章肠道疾病检测市场：依疾病的估计与趋势分析

  • 特定疾病的仪表板
  • 肠病检测市场：产业趋势分析
  • 全球肠病检测市场：按疾病分類的市场规模和趋势分析（2018-2030 年）
  • 细菌
    • 市场估计与预测（2018-2030）
    • 艰难梭菌
    • 曲状桿菌
    • 霍乱
    • 大肠桿菌
    • 幽门螺旋桿菌
    • 沙门氏菌病
    • 志贺氏菌症
  • 病毒
    • 市场估计与预测（2018-2030）
    • 轮状病毒
    • 诺罗病毒
  • 寄生虫
    • 市场估计与预测（2018-2030）
    • 阿米巴病
    • 隐孢子虫病
    • 贾第鞭毛虫病

第五章肠道疾病检测市场：按地区估计和趋势分析

  • 市场仪表板：按地区
  • 各地区市场占有率分析（2024 年及 2030 年）
  • 肠病检测市场：按地区分類的关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析（2024年）
  • 公司简介
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris Bioconcept
    • DiaSorin SpA
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is anticipated to reach USD 4.74 billion by 2030 and is anticipated to expand at a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of enteric diseases and the rising adoption of advanced diagnostic technologies are the major factors contributing to market growth. According to the U.S. Center for Disease Control and Prevention, nearly 11 and 21 million cases of typhoid fever and approximately 5 million paratyphoid fever cases are recorded worldwide each year.

The increasing incidence of gastrointestinal infections in multiple regions, driven by changing lifestyles and consumer preferences, has generated greater demand for enteric disease testing solutions. Growing awareness regarding the severe effects of enteric diseases, if not intervened in time, has led to the rising number of tests. The focus of multiple government agencies on protecting public health and preventing outbreaks is also expected to drive the growth of this industry in the coming years.

Government initiatives for improved healthcare, including screening programs, awareness campaigns, and specific welfare schemes, are projected to fuel market growth. For instance, in the U.S., the Centers for Disease Control and Prevention (CDC) uses the System for Enteric Disease Response, Investigation, and Coordination (SEDRIC) to ensure efficient surveillance and response to disease outbreaks linked to food or animal contact. It also helps manage the BEAM (Bacteria, Enterics, Ameba, and Mycotics) Dashboard, which provides enteric disease outbreak data to public viewers. Such initiatives are expected to result in increased testing in the forecast period.

Enteric Disease Testing Market Report Highlights:

  • The bacterial segment dominated the enteric disease testing market with nearly 60% share in 2024 owing to many bacteria, such as C. difficile, E. coli, Shigella, and Salmonella, which cause common enteric diseases.
  • The parasitic segment is expected to experience growth due to increasing cases of enteric diseases driven by contaminated water and food, poor sanitation systems in various regions, and lack of adequate hygiene.
  • The growing focus of multiple governments on offering improved healthcare services that feature advanced diagnostic technologies to prevent large-scale outbreaks is expected to create growth opportunities.
  • North America dominated the global industry in 2024 owing to factors such as a robust healthcare infrastructure and the presence of key diagnostic technology developers and biotechnology companies.
  • Preventive measures embraced by local agencies and government-funded research programs are anticipated to fuel growth.
  • In February 2025, BIOMERIEUX announced that it received clearance from the U.S. FDA for its new testing solution, BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Outlook
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Enteric Diseases Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis

  • 4.1. Disease Segment Dashboard
  • 4.2. Enteric Diseases Testing Market: Industry Movement Analysis
  • 4.3. Global Enteric Diseases Testing Market Size & Trend Analysis, by Disease , 2018 to 2030 (USD Million)
  • 4.4. Bacterial
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. C. Difficile
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Campylobacteriosis
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cholera
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. E. Coli
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. H. Pylori
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Salmonellosis
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Shigellosis
      • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Viral
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Rotavirus
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Norovirus
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Parasitic
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Amebiasis
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Cryptosporidiosis
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Giardiasis
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Continuous bioprocessing market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. UK
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Norway
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamics
      • 5.5.8.2. Regulatory framework/ reimbursement structure
      • 5.5.8.3. Competitive scenario
      • 5.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Japan
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. China
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Australia
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Brazil
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Argentina
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. South Africa
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Saudi Arabia
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. UAE
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.4. Kuwait
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Regulatory framework/ reimbursement structure
      • 5.8.4.3. Competitive scenario
      • 5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Abbott
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. BD
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Biomerica
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. BIOMERIEUX
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Bio-Rad Laboratories, Inc.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Cepheid
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Coris Bioconcept
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. DiaSorin S.p.A.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Meridian Bioscience
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Quest Diagnostics Incorporated
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 6 Mexico enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 8 Europe enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 10 Germany enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 France enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 12 Italy enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 13 Spain enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Denmark enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 15 Sweden enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 16 Norway enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Japan enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 India enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Australia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Thailand enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 26 Latin America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Brazil enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 29 Middle East & Africa enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Middle East & Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Enteric disease testing market: market outlook
  • Fig. 10 Enteric disease competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Enteric disease testing market driver impact
  • Fig. 16 Enteric disease testing market restraint impact
  • Fig. 17 Enteric disease testing market strategic initiatives analysis
  • Fig. 18 Global enteric disease testing market: Disease movement analysis
  • Fig. 19 Global enteric disease testing market: Disease outlook and key takeaways
  • Fig. 20 Bacterial enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Viral enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Rotavirus testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Norovirus testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Parasitic enteric disease testing market estimates and forecast, 2018-203
  • Fig. 25 Global enteric disease testing market: Regional movement analysis
  • Fig. 26 Global enteric disease testing market: Regional outlook and key takeaways
  • Fig. 27 North America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 28 U.S. enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 29 Canada enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 30 Mexico enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 34 France enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 37 Denmark enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 41 China enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 43 India enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 44 Thailand enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 45 South Korea enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 49 Argentina enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 50 Middle East and Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 51 South Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 53 UAE enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 54 Kuwait enteric disease testing market estimates and forecasts, 2018 - 2030